1. Home
  2. ZURA vs AVNW Comparison

ZURA vs AVNW Comparison

Compare ZURA & AVNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZURA
  • AVNW
  • Stock Information
  • Founded
  • ZURA 2022
  • AVNW 2006
  • Country
  • ZURA United States
  • AVNW United States
  • Employees
  • ZURA N/A
  • AVNW N/A
  • Industry
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • AVNW Radio And Television Broadcasting And Communications Equipment
  • Sector
  • ZURA Health Care
  • AVNW Technology
  • Exchange
  • ZURA Nasdaq
  • AVNW Nasdaq
  • Market Cap
  • ZURA 69.9M
  • AVNW 291.3M
  • IPO Year
  • ZURA N/A
  • AVNW 2007
  • Fundamental
  • Price
  • ZURA $1.12
  • AVNW $24.61
  • Analyst Decision
  • ZURA Buy
  • AVNW Strong Buy
  • Analyst Count
  • ZURA 7
  • AVNW 5
  • Target Price
  • ZURA $14.33
  • AVNW $37.60
  • AVG Volume (30 Days)
  • ZURA 771.4K
  • AVNW 97.3K
  • Earning Date
  • ZURA 08-08-2025
  • AVNW 05-06-2025
  • Dividend Yield
  • ZURA N/A
  • AVNW N/A
  • EPS Growth
  • ZURA N/A
  • AVNW N/A
  • EPS
  • ZURA N/A
  • AVNW N/A
  • Revenue
  • ZURA N/A
  • AVNW $435,926,000.00
  • Revenue This Year
  • ZURA N/A
  • AVNW $8.46
  • Revenue Next Year
  • ZURA N/A
  • AVNW $5.21
  • P/E Ratio
  • ZURA N/A
  • AVNW N/A
  • Revenue Growth
  • ZURA N/A
  • AVNW 14.58
  • 52 Week Low
  • ZURA $0.97
  • AVNW $12.96
  • 52 Week High
  • ZURA $5.07
  • AVNW $31.74
  • Technical
  • Relative Strength Index (RSI)
  • ZURA 47.71
  • AVNW 71.75
  • Support Level
  • ZURA $1.00
  • AVNW $23.81
  • Resistance Level
  • ZURA $1.22
  • AVNW $22.94
  • Average True Range (ATR)
  • ZURA 0.09
  • AVNW 0.72
  • MACD
  • ZURA -0.01
  • AVNW 0.10
  • Stochastic Oscillator
  • ZURA 43.64
  • AVNW 87.90

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

About AVNW Aviat Networks Inc.

Aviat Networks Inc is a networking solutions provider. It designs, manufactures and sells wireless networking products, solutions, and services to mobile and fixed operators, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast network operators around the world. The company's product categories include point-to-point microwave and millimeter wave radios that are licensed (subject to local frequency regulatory requirements), lightly licensed and license-exempt (operating in license-exempt frequencies), and element and network management software.

Share on Social Networks: